Molecular-Guided Therapy for Childhood Cancer
Public ClinicalTrials.gov record NCT02162732. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to test the feasibility (ability to be done) of experimental technologies to determine a tumor's molecular makeup. This technology includes a genomic report based on DNA exomes and RNA sequencing that will be used to discover new ways to understand cancers and potentially predict the best treatments for patients with cancer in the future.
Study identification
- NCT ID
- NCT02162732
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 186 participants
Conditions and interventions
Conditions
- Neuroblastoma
- Medulloblastoma
- Glioma
- Ependymoma
- Choroid Plexus Neoplasms
- Craniopharyngioma
- Dysembryoplastic Neuroepithelial Tumor
- Meningioma
- Primitive Neuroectodermal Tumors (PNETs)
- Germ Cell Tumors
- Rhabdomyosarcoma
- Non-rhabdomyosarcoma
- Ewings Sarcoma
- Osteosarcoma
- Wilms Tumor
- Renal Cell Carcinoma
- Malignant Rhabdoid Tumor
- Clear Cell Sarcoma
- Liver Tumors
Eligibility (public fields only)
- Age range
- 13 Months to 21 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 7, 2014
- Primary completion
- Jan 17, 2024
- Completion
- Jan 17, 2024
- Last update posted
- Nov 2, 2025
2014 – 2024
United States locations
- U.S. sites
- 18
- U.S. states
- 16
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arkansas Children's Hospital | Little Rock | Arkansas | 72202 | — |
| Rady Children's Hospital | San Diego | California | 92123 | — |
| Connecticut Children's Hospital | Hartford | Connecticut | 06106 | — |
| Arnold Palmer Hospital for Children | Orlando | Florida | 32806 | — |
| Kapiolani Medical Center for Women and Children | Honolulu | Hawaii | 96813 | — |
| Helen DeVos Children's Hospital | Grand Rapids | Michigan | 49503 | — |
| Children's Hospital and Clinics on Minnesota | Minneapolis | Minnesota | 55404 | — |
| Children's Mercy Hospitals and Clinics | Kansas City | Missouri | 64108 | — |
| Cardinal Glennon Children's Medical Center | St Louis | Missouri | 63104 | — |
| The Children's Hospital at Montefiore | The Bronx | New York | 10467 | — |
| Levine Children's Hospital | Charlotte | North Carolina | 28204 | — |
| Randall Children's Hospital | Portland | Oregon | — | — |
| Penn State Milton S. Hershey Medical Center and Children's Hospital | Hershey | Pennsylvania | 17033 | — |
| Medical University of South Carolina | Charleston | South Carolina | 29425 | — |
| Monroe Carrell Jr. Children's Hospital at Vanderbilt | Nashville | Tennessee | 37232 | — |
| Dell Children's Blood and Cancer Center | Austin | Texas | 78723 | — |
| Texas Children's Cancer and Hematology Centers | Houston | Texas | 77030 | — |
| Primary Children's Hospital | Salt Lake City | Utah | 84113 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02162732, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 2, 2025 · Synced Sep 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02162732 live on ClinicalTrials.gov.